{"url":"https://newsforagent.com/news/2026-10-27/globe-life-medicare-claims-investigation","markdown_url":"https://newsforagent.com/news/2026-10-27/globe-life-medicare-claims-investigation.md","title":"Globe Life Discloses $7 Million in Excess Medicare Claims","headline":"Globe Life Discloses $7 Million in Excess Medicare Supplement Claims as Shares Fall 8%","description":"Globe Life disclosed $7 million in excess Medicare Supplement claims tied to a CMS processing delay, and shares fell over 8% as an investigation opened.","section":"Legal & Disputes","published_at":"2026-10-27T00:11:06+00:00","modified_at":"2026-10-27T00:11:06+00:00","author":"News Desk","key_takeaways":["Globe Life disclosed approximately $7 million in excess prior-period Medicare Supplement claims tied to a CMS processing delay.","United American, Globe Life's Medicare Supplement division, reported a negative $6 million health underwriting margin on $219 million in health premiums for the quarter ended September 30, 2026.","SueWallSt, powered by Levi & Korsinsky LLP, notified investors of a pending investigation into potential securities law violations concerning Globe Life's disclosure of its CMS claims exposure."],"companies":[{"name":"Globe Life","is_primary":true,"profile_url":"https://akta.pro/company-profiles/0002zlc/globe-life","website":"https://www.globelifeinsurance.com"},{"name":"SueWallSt.com","is_primary":false,"profile_url":"https://akta.pro/company-profiles/00st1t3/suewallst-com","website":"https://www.suewallst.com"},{"name":"Levi & Korsinsky","is_primary":false,"profile_url":"https://akta.pro/company-profiles/00026sm/levi-korsinsky","website":"http://www.zlk.com"}],"source":{"publisher":"PR Newswire","title":"Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL)","url":"https://www.prnewswire.com/news-releases/globe-life-inc-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-globe-life-inc-gl-302919923.html"},"other_sources":[],"tags":["Legal & Disputes","Globe Life","SueWallSt.com","Levi & Korsinsky"],"body_markdown":"Globe Life Inc. disclosed approximately $7 million in excess prior-period Medicare Supplement claims tied to a processing delay at the Centers for Medicare & Medicaid Services, and its shares fell over 8% on October 23, 2026. SueWallSt notified investors of a pending investigation into potential securities law violations, according to [PR Newswire](https://www.prnewswire.com/news-releases/globe-life-inc-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-globe-life-inc-gl-302919923.html).\n\n## Globe Life's Third-Quarter Claims Disclosure\n\nThe excess claims landed in United American, the [Globe Life](https://akta.pro/company-profiles/0002zlc/globe-life) division that writes Medicare Supplement coverage. For the quarter ended September 30, 2026, United American reported a health underwriting margin of negative $6 million on $219 million in health premiums. Globe Life said the excess claims related to prior periods and were paid because of the CMS processing delay. United American's health premiums rose 29% year over year, and health sales climbed 95% to $48 million. Globe Life reported the CMS-related claims with its third-quarter results on October 22, 2026.\n\nThe investigation concerns whether Globe Life may not have adequately disclosed its exposure to CMS claims-processing changes before that date. Joseph E. Levi, Esq. of [Levi & Korsinsky](https://akta.pro/company-profiles/00026sm/levi-korsinsky) said investors who bought Globe Life stock and are looking at losses can submit their loss details. \"Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares,\" the notice states.\n\n## Globe Life's Scale and Capital Moves\n\nGlobe Life is a publicly traded U.S. insurance holding company that underwrites life insurance, supplemental health, Medicare Supplement, and group benefits for middle-income American households through 17,000 captive agents and direct-to-consumer channels, according to akta.pro [company records](https://akta.pro/company-data). The same records show full-year 2025 revenue of $6.02 billion and a market capitalization of $13.65 billion as of June 2026, when the stock reached an all-time high of $176.31. In April 2026, Globe Life completed a $1.2 billion Bermuda reinsurance transaction through its newly established Globe Life Re Ltd. subsidiary.\n\n## Earlier Globe Life Developments\n\nOn October 26, 2026, Levi & Korsinsky commenced an investigation into Globe Life for potential securities fraud, after shares fell 8.09% when management cut its full-year 2026 earnings outlook, citing health-insurance underwriting pressures and a third-quarter earnings miss, [The future of trading](https://akta.pro/news-signals) reported. Globe Life set its third-quarter 2026 earnings release for October 21, 2026, with a conference call, Stock Titan reported on October 19, 2026. In September 2026, Globe Life reported second-quarter revenues of $1.59 billion, up 6.1% year on year, but missed book value and EPS estimates, sending its stock down 7% to $171.17, Yahoo reported.\n\n## What Comes Next for Globe Life\n\nGlobe Life released its third-quarter 2026 financial results after the market close on October 21, 2026, and held a conference call for the release. The SueWallSt investigation remains pending, and investors may submit brokerage records showing purchase dates, share quantities, and prices paid.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}